Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Berlin

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Randomized, placebo-controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitisT J Simon, M M Berenson, R G Berlin, et al.
Gastroenterology|May 1, 1991
P450/losecP Moldéus, R G Berlin, A Lu, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1990
Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humansW E Karnes, R G Berlin, V Maxwell, et al.
Archives of Internal Medicine|December 1, 1991
Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study GroupS M Sabesin, R G Berlin, T J Humphries, et al.
Clinical Therapeutics|November 1, 1995
Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitisT J Simon, W G Roberts, R G Berlin, et al.
Digestive Diseases and Sciences|February 1, 1995
Safety of acid-suppressing drugsR A Smallwood, R G Berlin, N Castagnoli, et al.
Digestive Diseases and Sciences|June 1, 1991
U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study GroupJ E Valenzuela, R G Berlin, W J Snape, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Alimentary Pharmacology & Therapeutics|February 1, 1994
Randomized, placebo-controlled comparison of famotidine 20 mg b.d. or 40 mg b.d. in patients with erosive oesophagitisT J Simon, M M Berenson, R G Berlin, et al.
Gastroenterology|May 1, 1991
P450/losecP Moldéus, R G Berlin, A Lu, et al.
Alimentary Pharmacology & Therapeutics|October 1, 1990
Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humansW E Karnes, R G Berlin, V Maxwell, et al.
Archives of Internal Medicine|December 1, 1991
Famotidine relieves symptoms of gastroesophageal reflux disease and heals erosions and ulcerations. Results of a multicenter, placebo-controlled, dose-ranging study. USA Merck Gastroesophageal Reflux Disease Study GroupS M Sabesin, R G Berlin, T J Humphries, et al.
Clinical Therapeutics|November 1, 1995
Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitisT J Simon, W G Roberts, R G Berlin, et al.
Digestive Diseases and Sciences|February 1, 1995
Safety of acid-suppressing drugsR A Smallwood, R G Berlin, N Castagnoli, et al.
Digestive Diseases and Sciences|June 1, 1991
U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study GroupJ E Valenzuela, R G Berlin, W J Snape, et al.
Gastroenterology|March 1, 1997
Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591W G Roberts, T J Simon, R G Berlin, et al.
Pageof 2